Neuren Pharmaceuticals | NEU - Current Assets

Stock Price
11.57
Daily Change
-0.19 -1.62%
Monthly
-9.61%
Yearly
-4.06%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD332.23M in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 35.49M 760K Dec/2025
Clinuvel Pharmaceuticals AUD 222.06M 20.56M Jun/2024
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Genetic Signatures AUD 42.96M 5.02M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
Medical Developments International AUD 33.75M 1.79M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Paradigm Biopharmaceuticals AUD 24.13M 8.16M Jun/2025
PYC Therapeutics AUD 153.74M 23.79M Dec/2025
Starpharma Holdings AUD 24.24M 1.68M Dec/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Telix Pharmaceuticals AUD 330.28M 67.73M Dec/2025
Viatris USD 9.79B 162.2M Dec/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025